Chargement en cours...
Bispecific Antibodies in the Treatment of Hematologic Malignancies
Monoclonal antibody therapies are an important approach for the treatment of hematologic malignancies, but typically show low single‐agent activity. Bispecific antibodies, however, redirect immune cells to the tumor for subsequent lysis, and preclinical and accruing clinical data support single‐agen...
Enregistré dans:
| Publié dans: | Clin Pharmacol Ther |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6766786/ https://ncbi.nlm.nih.gov/pubmed/30770546 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.1396 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|